Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Aug 2023
Historique:
received: 29 06 2023
revised: 05 08 2023
accepted: 08 08 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Despite the advances made in treatment, the prognosis of pancreatic ductal adenocarcinoma (PDAC) remains dismal, even in the locoregional and locally advanced stages, with high relapse rates after surgery. PDAC exhibits a chemoresistant and immunosuppressive phenotype, and the tumor microenvironment (TME) surrounding cancer cells actively participates in creating a stromal barrier to chemotherapy and an immunosuppressive environment. Recently, there has been an increasing use of interventional radiology techniques for the treatment of PDAC, although they do not represent a standard of care and are not included in clinical guidelines. Local approaches such as radiation therapy, hyperthermia, microwave or radiofrequency ablation, irreversible electroporation and high-intensity focused ultrasound exert their action on the tumor tissue, altering the composition and structure of TME and potentially enhancing the action of chemotherapy. Moreover, their action can increase antigen release and presentation with T-cell activation and reduction tumor-induced immune suppression. This review summarizes the current evidence on locoregional therapies in PDAC and their effect on remodeling TME to make it more susceptible to the action of antitumor agents.

Identifiants

pubmed: 37628865
pii: ijms241612681
doi: 10.3390/ijms241612681
pmc: PMC10454061
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2021 Dec 14;22(24):
pubmed: 34948209
Clin Cancer Res. 2022 Jan 1;28(1):150-162
pubmed: 34862242
Mol Cancer. 2018 Jul 30;17(1):108
pubmed: 30060755
Sci Rep. 2019 Feb 4;9(1):1310
pubmed: 30718678
Minim Invasive Ther Allied Technol. 2018 Feb;27(1):33-40
pubmed: 29278340
Cardiovasc Intervent Radiol. 2010 Feb;33(1):11-7
pubmed: 19924474
Br J Cancer. 2020 Feb;122(4):498-505
pubmed: 31857726
Cardiovasc Intervent Radiol. 2014 Jun;37(3):586-91
pubmed: 23989503
Ann Biomed Eng. 2021 Sep;49(9):1975-1991
pubmed: 34374945
Ann Gastroenterol Surg. 2019 Jan 04;3(2):130-137
pubmed: 30923782
Gastroenterology. 2013 Nov;145(5):1121-32
pubmed: 23891972
J Cancer Res Ther. 2022 Dec;18(7):1945-1951
pubmed: 36647954
Pancreas. 2013 Oct;42(7):1143-9
pubmed: 23899940
World J Gastrointest Oncol. 2022 Feb 15;14(2):533-542
pubmed: 35317325
Nano Lett. 2017 Feb 8;17(2):652-659
pubmed: 28094959
Radiology. 2005 Aug;236(2):495-502
pubmed: 16040906
Radiol Med. 2022 Feb;127(2):214-219
pubmed: 35034325
Onco Targets Ther. 2019 Feb 01;12:1021-1029
pubmed: 30774386
N Engl J Med. 2009 Nov 19;361(21):2094-6
pubmed: 19923581
Radiol Med. 2013 Sep;118(6):949-61
pubmed: 23892957
JAMA Oncol. 2021 Mar 1;7(3):421-427
pubmed: 33475684
Life (Basel). 2023 Mar 20;13(3):
pubmed: 36983990
Front Med (Lausanne). 2021 Feb 11;7:624997
pubmed: 33644089
Radiol Med. 2014 Jul;119(7):483-98
pubmed: 24981482
Front Oncol. 2021 Jan 14;10:621937
pubmed: 33520728
Front Med China. 2010 Sep;4(3):294-302
pubmed: 21191835
Sci Rep. 2019 Dec 12;9(1):18916
pubmed: 31831785
World J Gastroenterol. 2021 Jun 21;27(23):3413-3428
pubmed: 34163121
Gastroenterol Res Pract. 2014;2014:205325
pubmed: 25053938
Immunology. 2009 Sep;128(1):141-9
pubmed: 19689743
J Clin Med. 2021 Apr 10;10(8):
pubmed: 33920118
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
Gland Surg. 2018 Apr;7(2):59-66
pubmed: 29770302
Front Oncol. 2022 Mar 18;12:853779
pubmed: 35372046
World J Gastroenterol. 2022 Apr 7;28(13):1288-1303
pubmed: 35645539
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Ther Adv Med Oncol. 2020 Sep 10;12:1758835920953728
pubmed: 32973929
Ann Surg. 2019 Aug;270(2):340-347
pubmed: 29596120
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Nat Rev Cancer. 2004 Oct;4(10):806-13
pubmed: 15510161
Chin Med J (Engl). 2002 Sep;115(9):1332-5
pubmed: 12411106
Genes Cancer. 2018 Mar;9(3-4):78-86
pubmed: 30108679
Cancer Biol Med. 2019 Nov;16(4):688-699
pubmed: 31908888
HPB (Oxford). 2013 Aug;15(8):623-7
pubmed: 23458679
J Inflamm Res. 2021 Sep 21;14:4795-4807
pubmed: 34584438
Cancer Lett. 2021 Nov 1;520:1-11
pubmed: 34216688
Radiol Med. 2014 Jul;119(7):533-40
pubmed: 25001585
Cell Death Dis. 2020 Jul 27;11(7):589
pubmed: 32719347
Technol Cancer Res Treat. 2017 Aug;16(4):393-405
pubmed: 27340260
Cancer Res. 2016 May 1;76(9):2525-39
pubmed: 26980767
Cancers (Basel). 2022 Jan 17;14(2):
pubmed: 35053614
Adv Sci (Weinh). 2022 Apr;9(10):e2105240
pubmed: 35128843
Pol J Radiol. 2023 Apr 18;88:e216-e224
pubmed: 37234463
ACS Nano. 2015 Feb 24;9(2):1280-93
pubmed: 25599568
Trials. 2021 Apr 29;22(1):313
pubmed: 33926539
Neoplasia. 2009 May;11(5):497-508
pubmed: 19412434
Surgery. 2020 Oct;168(4):610-616
pubmed: 32631655
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):320-3
pubmed: 16168826
Acta Oncol. 2006;45(7):823-30
pubmed: 16982546
Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1145-9
pubmed: 1657839
J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S179-86
pubmed: 20656227
J Vasc Interv Radiol. 2018 Dec;29(12):1764-1769
pubmed: 30316676
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231157193
pubmed: 36916200
Annu Rev Pathol. 2023 Jan 24;18:123-148
pubmed: 36130070
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
J Clin Oncol. 2019 May 1;37(13):1062-1069
pubmed: 30817250
Int J Hyperthermia. 2010;26(2):198-208
pubmed: 20146573
World J Gastroenterol. 2008 Mar 14;14(10):1603-11
pubmed: 18330956
Int J Surg. 2008;6 Suppl 1:S65-9
pubmed: 19186116
Int J Hyperthermia. 2007 Mar;23(2):89-104
pubmed: 17578335
Br J Anaesth. 2014 Dec;113(6):985-92
pubmed: 25173767
Phys Med Biol. 2019 Jun 20;64(12):125018
pubmed: 31071701
Oncogene. 2016 Nov 10;35(45):5882-5892
pubmed: 27109098
Biomedicines. 2022 Feb 15;10(2):
pubmed: 35203660
Cancer Chemother Pharmacol. 2012 Jan;69(1):115-23
pubmed: 21626049
Endosc Ultrasound. 2020 May-Jun;9(3):167-174
pubmed: 31031330
Br J Cancer. 2021 Jan;124(2):333-344
pubmed: 32929194
Gastrointest Endosc. 2022 Jun;95(6):1067-1077.e15
pubmed: 35124072
Sci Rep. 2019 Mar 28;9(1):5303
pubmed: 30923340
Cell Death Differ. 2019 Jan;26(2):382-393
pubmed: 30283082
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):274-83
pubmed: 16618582
Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G709-17
pubmed: 18669622
Gastrointest Cancer Res. 2009 Jan;3(1):20-8
pubmed: 19343134
Ann Gastroenterol Surg. 2019 Apr 25;3(4):368-372
pubmed: 31346575
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
Front Oncol. 2020 Jan 31;10:41
pubmed: 32083002
Front Cell Dev Biol. 2021 Jul 15;9:655152
pubmed: 34336821
Nat Rev Clin Oncol. 2020 Sep;17(9):527-540
pubmed: 32398706
Sci Rep. 2017 Jun 13;7(1):3437
pubmed: 28611425
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
J Clin Oncol. 2020 Sep 20;38(27):3185-3194
pubmed: 32706635
Front Oncol. 2023 Jan 11;12:1060885
pubmed: 36713520
Clin Cancer Res. 2021 Apr 1;27(7):2023-2037
pubmed: 33495315
Radiology. 2009 Apr;251(1):1-2
pubmed: 19332838
Radiology. 2011 Feb;258(2):351-69
pubmed: 21273519
J Clin Oncol. 1997 Jun;15(6):2403-13
pubmed: 9196156
Oncologist. 2019 Oct;24(10):e990-e1005
pubmed: 31217342
Cancer Res. 2007 Oct 1;67(19):9518-27
pubmed: 17909062
Clin Cancer Res. 2004 Oct 15;10(20):6956-61
pubmed: 15501974
Eur Radiol. 2021 May;31(5):3530-3541
pubmed: 33155107
J Interv Med. 2021 Aug 14;4(4):159-171
pubmed: 35586384
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1017-21
pubmed: 15001240
J Control Release. 2016 Dec 10;243:172-181
pubmed: 27744037
Cells. 2022 Sep 21;11(19):
pubmed: 36230914
Mol Cell Biol. 2004 Apr;24(7):2875-89
pubmed: 15024076
Tech Vasc Interv Radiol. 2020 Jun;23(2):100675
pubmed: 32591191
Cancer Immunol Res. 2023 Jan 3;11(1):4-12
pubmed: 36367967
J Immunother. 2009 Jan;32(1):12-21
pubmed: 19307989
World J Gastroenterol. 2021 Jul 21;27(27):4322-4341
pubmed: 34366607
Cancers (Basel). 2018 Jan 10;10(1):
pubmed: 29320420
Br J Cancer. 2018 Nov;119(10):1208-1214
pubmed: 30318515
J Med Ultrason (2001). 2022 May 12;:
pubmed: 35551555
World J Gastrointest Oncol. 2018 Aug 15;10(8):202-210
pubmed: 30147846
Eur J Cancer. 2022 Jan;160:140-149
pubmed: 34838371
Cancer Res. 2013 Jun 1;73(11):3235-47
pubmed: 23633488
Cancer Res. 2015 Sep 15;75(18):3738-46
pubmed: 26216548
Cancers (Basel). 2021 Oct 11;13(20):
pubmed: 34680235
Expert Rev Gastroenterol Hepatol. 2021 Jul;15(7):821-828
pubmed: 33481633
Cancers (Basel). 2020 Dec 15;12(12):
pubmed: 33333727
Nat Commun. 2019 Feb 22;10(1):899
pubmed: 30796212
Abdom Radiol (NY). 2022 Jan;47(1):254-264
pubmed: 34718835
Gut. 2012 Feb;61(2):172-8
pubmed: 22115911
Ultraschall Med. 2022 Aug;43(4):380-386
pubmed: 32797463
J Vasc Interv Radiol. 2013 Oct;24(10):1513-20
pubmed: 24070507
Front Immunol. 2022 Jan 07;12:811726
pubmed: 35069599
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
World J Gastroenterol. 2016 Jan 14;22(2):790-800
pubmed: 26811625
J Clin Oncol. 2015 Dec 20;33(36):4284-92
pubmed: 26527777
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):445-53
pubmed: 15145161
Cancers (Basel). 2021 Aug 02;13(15):
pubmed: 34359801
Clin Cancer Res. 2008 Oct 1;14(19):5995-6004
pubmed: 18829478
Abdom Radiol (NY). 2019 Aug;44(8):2801-2808
pubmed: 31025067
Curr Oncol. 2022 Sep 21;29(10):6754-6763
pubmed: 36290808
Mol Cancer. 2019 Jan 21;18(1):14
pubmed: 30665410
Gut. 2008 Oct;57(10):1420-30
pubmed: 18515410

Auteurs

Maria Caterina De Grandis (MC)

Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.

Velio Ascenti (V)

Postgraduate School of Diagnostic and Interventional Radiology, University of Milan, 20122 Milan, Italy.

Carolina Lanza (C)

Postgraduate School of Diagnostic and Interventional Radiology, University of Milan, 20122 Milan, Italy.

Giacomo Di Paolo (G)

Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.

Barbara Galassi (B)

Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Anna Maria Ierardi (AM)

Radiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Gianpaolo Carrafiello (G)

Radiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Oncology and Haemato-Oncology, University of Milan, 20122 Milan, Italy.

Antonio Facciorusso (A)

Section of Gastroenterology, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Michele Ghidini (M)

Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH